“Only one person was conspicuously missing from the (American Society of Clinical Oncology, ASCO) party - Dennis Slamon. Having spent the afternoon planning the next phase of Herceptin trials with breast oncologists at ASCO, Slamon had jumped into his rundown… — Siddhartha Mukherjee Copy Share Image
